Cite

HARVARD Citation

    Dupont, R. et al. (2020). The prognostic impact of immune-related adverse events during anti-PD1 treatment in melanoma and non–small-cell lung cancer: a real-life retrospective study. Oncoimmunology. p. . [Online]. 
  
Back to record